UK markets closed

Defence Therapeutics Inc. (DTCFF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.08000.0000 (0.00%)
As of 09:30AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 48.21M
Enterprise value 49.05M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)91.11
Enterprise value/revenue N/A
Enterprise value/EBITDA -6.98

Trading information

Stock price history

Beta (5Y monthly) 1.40
52-week change 3-57.81%
S&P500 52-week change 321.83%
52-week high 33.1900
52-week low 30.9900
50-day moving average 31.3227
200-day moving average 31.7835

Share statistics

Avg vol (3-month) 3176
Avg vol (10-day) 3269
Shares outstanding 545.44M
Implied shares outstanding 646.72M
Float 842.55M
% held by insiders 14.73%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-1,496.29%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -13.34M
Net income avi to common (ttm)-13.59M
Diluted EPS (ttm)-0.1400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)351k
Total cash per share (mrq)0.01
Total debt (mrq)1.51M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.18
Book value per share (mrq)-0.05

Cash flow statement

Operating cash flow (ttm)-6.77M
Levered free cash flow (ttm)-2.03M